AAAman Agarwal

Aman Agarwal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aman Agarwal has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • From Inflamed Gums to Infected Heart: Linking Periodontal Diseases and Myocardial Infarction

    by Aman Agarwal, Srishty Mbbs Agarwal, Mohammad Mbbs Hazique, Lavanya Bansal, Himanshi Mbbs Banker, Deepshikha Dmd Kapoor, Priyanka Dmd Jain, Rohit Jain

    Periodontal disease is a chronic inflammatory condition that affects the tissues that support the teeth. It has been linked with various systemic conditions such as cardiovascular disorders, respiratory conditions, and diabetes, reinforcing the concept of oral-systemic hygiene. With its high prevalence and significant economic burden, periodontal disease has become a critical public health concern, impacting 11.2% of the global adult population. This article aims to discuss the association between periodontal disease and the mechanisms leading to the development of myocardial infarction (MI). This condition occurs due to ischemia of heart muscle tissue from lack of blood supply for a prolonged period, which further leads to systolic dysfunction, metabolic derangements, and cellular death. Several studies have discovered a link between MI and dental disorders, raising the possibility that inflammation brought on by periodontitis may increase cardiovascular risk. Bacterial translocation, endotoxins from gram-negative pathogens, cytokines, and platelet activation are the major players leading to severe inflammatory conditions that influence the progression of atherosclerosis, further leading to MI. Autoimmune processes with homologous heat shock proteins from bacterial pathogens also trigger cellular and humoral immune responses, linking periodontal diseases and MI. Since periodontal disease may serve as a modifiable risk factor for MI, public health needs to comprehend the relationship between oral health and MI. Recent studies have identified the need to look for biomarkers that may correlate with the aforementioned health conditions, laying greater emphasis on the development of standardized protocols for risk mitigation and the need for tailored therapies.


  • Open Access

    Precision medicine approaches in epilepsy: A systematic review of genetic markers and personalized treatment strategies

    by Aman Agarwal, Ravneet Kaur, Faiza Ashfaque, Zeenat Hadi, Muhammad Wajeeh Anis, Ahila Ali, Simran Ochani, Al Hasibuzzaman

    Epilepsy is one of the most common neurological diseases globally. We conducted a systematic review of the genetic markers and personalized treatment strategies used in the precision medicine treatment of epilepsy. An exhaustive electronic search was carried out on PubMed and Google Scholar, spanning from inception up to June 2023 on epilepsy and biomarkers. A total of 45 articles from PubMed and 19 articles from Google Scholar were imported and screened based on studies that focused primarily on genetic markers and precision methods for epilepsy subtyping, treatment strategies, outcomes, and adverse effects. Reviews and studies not in English were excluded. Full‐text data extraction, coding, and analysis were carried out with Microsoft Excel. For the risk of bias assessment of the final included studies, the Critical Appraisal Skills Program checklist was used. A total of 19 studies were analyzed in the review. The SLC35A2 gene saw a reduction in seizure frequency with d‐galactose treatment while the KCNQ2 gene saw improvement with phenytoin, carbamazepine, and retigabine. GRIN2D gene saw varying improvements with memantine. KCNT1 gene saw improvement with only a combination of quinidine and topiramate, quinidine was not useful when used alone. Other studies involved the identification of different markers using gene and exome sequencing. These studies collectively provide a diverse range of insights into epilepsy, with variations in study design, sample size, age groups, and diagnostic criteria, highlighting the multifaceted nature of epilepsy research. These studies contribute to our understanding of epilepsy diagnosis and management in different clinical settings, however, there were some limitations such as QT prolongation was observed with specific medications and participant heterogeneity. Small sample sizes reduced statistical power and brief durations of studies limited their ability for long‐term analysis. Although most studies had a low risk of bias, two studies demonstrated some reporting bias. Fianlly, the absence of biomarkers is a limitation that impedes the study's capacity to explore underlying biological mechanisms.


  • Open Access

    Evaluation of non-invasive diagnostic tools for diarrhea: a systematic review of point-of-care tests and biomarkers

    by Hinal Rd Year Mbbs Patel, Ravneet Kaur, Mohammad Haris Ali, Zeenat Graduated Hadi, Anushri Final Year Student(Mbbs) Parikh, Sheharyar Hassan Graduated In Khan, Maniteja Graduated In Kamireddy, Haseeb Faiz, Yashkumar Girdharlal Graduated In Kamani, Aman Rd Year Mbbs Agarwal, et al.

    Background: Diarrhea is a prevalent condition affecting millions worldwide. However, current standard diagnostic methods have many drawbacks. This review examines various non-invasive point-of-care (POC) tests and biomarkers aiding rapid diagnosis of diarrhea from different causes. Methods: PubMed, PubMed Central, ScienceDirect, Cochrane Library, and Google Scholar were searched from 2013 to present for relevant literature. Two reviewers independently assessed included studies’ quality using the Critical Appraisal Skills Programme (CASP) checklist. Results: The search yielded 1453 studies, of which 39 were included after screening and applying eligibility criteria. Polymerase chain reaction (PCR) was the POC test in 25 studies, providing consistent sensitivity and specificity. For biomarkers, C-reactive protein (CRP), fecal calprotectin, and procalcitonin offered high sensitivity and specificity for conditions like acute pediatric diarrhea, microscopic colitis, and inflammatory diarrhea, respectively. Conclusion: PCR proved the ideal POC test for rapid diarrhea diagnosis, while the procalcitonin biomarker helps differentiate inflammatory from non-inflammatory diarrhea. Other reviewed tools also demonstrated promising diagnostic performance, though improvements in sensitivity, specificity, and usability are still needed.


  • Blood borne infections and Hepatitis B virus immunization levels among medical students in India

    by Anju Sharma, Vikas Manchanda, Aman Agarwal, Advitiya Kapoor, Sunil Kumar, Sonal Saxena


  • Open Access

    Circulating levels of leptin in different phases of the menstrual cycle – a systematic review and meta-analysis

    by Suhrud J. Panchawagh, Pratyush Kumar, Shabarini Srikumar, Khushi Prajapati, Manali Sarkar, Kumar Abhishek, Poonam Agrawal, G. P. Kaushal, Daniel Jesús García Martínez, Swati Kalra, et al.

    Leptin is a peptide hormone synthesized by white adipose tissue. Its principal site of action is in the brainstem and hypothalamus, where it acts to modulate satiety and control of reward and aversion. Leptin deficiency or resistance is associated with dysregulation of cytokine production, increased susceptibility to infections, autoimmune disorders, malnutrition, and inflammatory responses. Studies have shown variation in leptin levels between males and females, and in different phases of the menstrual cycle as well. Our study aims to explain the variation in leptin levels and their physiological role in the menstrual cycle. A total of 1887 records were identified from PubMed, Google Scholar, and Cochrane. We included studies where females were 18-40 years of age, who had achieved menarche, and were on regular menstrual cycles. We excluded studies which were cross-section, pre-prints, or studies where inadequate information was provided. Seven studies were included in the study. We used the standardized mean difference as the outcome measure. Leptin levels varied significantly in the phases of the menstrual cycle as well as during prepubertal, pubertal, and postpubertal phases. The standardized mean difference in leptin levels between the follicular phase and the luteal phase was 2.67 ng/mL (95% CI: 0.16 to 5.19 ng/mL). Fluctuations in leptin levels can cause weight changes and reproductive cycle disturbances. Hence, in cases of infertility with abnormal menstrual cycles, measurement of the physiologic variability in leptin levels may help to diagnose the cause of infertility and appropriate interventions can be started.